Estimated glomerular filtration rate is a biomarker of cognitive impairment in Parkinson's disease.

eGFR is altered in PD subjects with cognitive impairment, and predict larger progression of cognitive decline. It may assist identifying patients with PD at risk of rapid cognitive decline and have the potential to monitoring responses to therapy in future clinical practice.